News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Novartis Buys US Drugmaker for Up To $665 Million
Tracy Vence | Nov 23, 2016
The Swiss pharma giant is acquiring Oklahoma-based Selexys Pharmaceuticals, a maker of drugs for inflammatory and thrombotic diseases.
The Growth of Iowa Biotech
Jenny Rood | Aug 1, 2016
The state’s industry draws inspiration from medicine as well as agriculture.
$1.5 Billion Pharma Buyout for Leukemia Drug
Jef Akst | Jun 1, 2016
Jazz Pharmaceuticals is set to purchase Celator to acquire an experimental treatment for acute myeloid leukemia.
Shire Buys Rare Disease Drug Developer
Tracy Vence | Nov 2, 2015
The Irish drugmaker is set to acquire the Massachusetts-based Dyax in a $5.9 billion deal.
Tracy Vence | Oct 22, 2015
A specialty pharmaceuticals company announces plans to produce a toxoplasmosis drug containing the same active ingredient as the pill at the center of an ongoing drug-pricing controversy.
Biotech Stocks Take a Hit
Kerry Grens | Sep 30, 2015
Some say the biotech bubble has burst over concerns that drug prices are too high—and may soon be regulated.
TS Picks: September 8, 2015
Jef Akst | Sep 8, 2015
Kate Yandell | Sep 1, 2015
For decades, the only remedies for hearing loss were devices such as hearing aids or cochlear implants. Now, the first pharmaceutical treatments may be on the way.
Valeant Scoops Sprout for $1 Billion
Tracy Vence | Aug 24, 2015
The Canadian pharmaceutical firm is buying the American drugmaker behind the newly approved “female Viagra.”
Legionnaires’ Bacteria at GSK
Jef Akst | Aug 14, 2015
GlaxoSmithKline temporarily shuts down a manufacturing plant in North Carolina after
bacteria are detected in two external cooling towers.